Advicenne SA logo

ADVIC - Advicenne SA News Story

€7.12 -0.1  -1.7%

Last Trade - 3:43pm

Sector
Healthcare
Size
Small Cap
Market Cap £55.1m
Enterprise Value £41.1m
Revenue £1.50m
Position in Universe 558th / 852

BRIEF-Advicenne FY Operating Loss Widens To 6.0 Million Euros

Tue 10th April, 2018 5:13pm
April 10 (Reuters) - ADVICENNE SA  ADVIC.PA :
    * FY REVENUE EUR 0.6 MILLION VERSUS EUR 0.3 MILLION YEAR AGO
    * FY OPERATING LOSS EUR 6.0 MILLION VERSUS LOSS EUR 3.2
MILLION
YEAR AGO
    * FY NET LOSS EUR 6.0 MILLION VERSUS LOSS EUR 3.6 MILLION
YEAR AGO
    * PLANS TO LAUNCH TWO PIVOTAL STUDIES WITH ADV7103 IN 2018
    * ADV7103: PLANS TO LAUNCH IN H2 PHASE II/III PIVOTAL
CLINICAL
TRIAL IN US IN DRTA PATIENTS
    * ADV7103: PLANS TO LAUNCH IN H1 PHASE II/III PIVOTAL
CLINICAL
TRIAL IN EUROPE IN CYSTINURIA PATIENTS
    * CASH AND CASH EQUIVALENTS AT END-DEC. EUR 36.2 MILLION

Source text : https://bit.ly/2HqTIoD
Further company coverage:  ADVIC.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 59 772 0920;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.